Speakers in Plenary
OPENING REMARKS: HKH Crownprincess Victoria of Sweden
Crown Princess of Sweden, Victoria, is heir to the Swedish throne. The Crown Princess is especially involved in issues related to crisis and conflict management, aid work and international peacekeeping activities. In January 2016, UN Secretary General Ban Ki-moon appointed The Crown Princess as a member of the Sustainable Development Goals Advocates for Agenda 2030. Between 2016-2018, The Crown Princess was one of 17 ambassadors in the Sustainable Development Goals (SDG) Advocacy Group with the task to promote the UN's Sustainable Development Goals – Agenda 2030 – in various ways. The Crown Princess is now part of the SDG Advocate Alumni and continue to work actively, primarily with issues concerning water and health, goal 6 and 14.
The Crown Princess is highly involved in issues concerning children and young people. The Crown Princess and her husband Prince Daniel established a foundation to mark the occasion of their marriage in 2010. The Crown Princess Couple’s foundation, aims to support children and young people in Sweden, with the purpose of combating exclusion and promoting good health.
SPEAKERS IN SESSION 1: Setting the scene
Dr Otto Cars is the founder and serves as senior adviser to the ReAct Group. He is also a Senior Professor of Infectious Disesases at Uppsala University. He is an MD and former head of the Department of Infectious Diseases at Uppsala University Hospital. In 2003, he was appointed Professor of Infectious Diseases and Antimicrobial Resistance at Uppsala University, and since 2014 he holds a position as Senior Professor.
Otto Cars was leading the Swedish strategic programme against antimicrobial resistance (Strama) on behalf of the Swedish government between 1995- 2010. He has served as an expert to the World Health Organization and several European Agencies and was as a member of the UN ad-hoc Interagency Coordination Group on Antimicrobial Resistance (IACG). Otto Cars is the founder of the international network Action on Antibiotic Resistance -ReAct ( www.reactgroup.org) which, supported by the Swedish International Development Cooperation Agency, since 2005 is working on all continents as a catalyst, advocating for and supporting multilevel engagement on antibiotic resistance.
Dr Keith Sumption is the Chief Veterinary Officer of the Food and Agriculture Organization of the United Nations (CVO-FAO). He is the Leader of the Animal Health Programme (NSAH), and Director of the Joint Centre for Zoonoses and antimicrobial resistance (AMR) (CJWZ).
He has worked on disease ecology at the interaction of wildlife, domestic and the environment for more than 30 years, from initial studies on how disease can affect ecosystem balances (for his first degree in Ecology), through PhD studies on African Swine Fever in wild and domestic hosts in southern Africa, and more than 17 years of management of epizootic diseases (Foot-and-mouth disease, FMD) in the wildlife –domestic interface as Secretary for the European Commission for the Control of Foot-and-Mouth Disease (EuFMD) Commission based in FAO. Since June 2020 he has been CVO for FAO, and since July, the Director of FAO’s Centre for Zoonoses and AMR (CJWZ), and leader of FAO’s animal health service.
Professor Dame Sally Davies is the UK Special Envoy on Antimicrobial Resistance. She was appointed as the UK Government’s Special Envoy on AMR in 2019. She is also the 40th Master of Trinity College at Cambridge University.
Dame Sally was the Chief Medical Officer for England and Senior Medical Advisor to the UK Government from 2011-2019. She has become a leading figure in global health including serving as a member of the World Health Organisation (WHO) Executive Board 2014-2016 and as co-convener of the United Nations Inter-Agency Co-ordination Group (IACG) on Antimicrobial Resistance (AMR), reporting in 2019. In November 2020, Dame Sally was announced as a member of the new Global Leaders Group on AMR. In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research, having received her DBE in 2009.
Dr Eldar Shafir is Class of 1987 Professor of Behavioral Science and Public Policy at Princeton University, Director of Princeton’s Kahneman-Treisman Center for Behavioral Science and Public Policy, and scientific director at ideas42, a non-for-profit social science R&D lab. His research focuses on cognitive science and behavioral economics, with particular interest in the application of behavioral research to policy. He is Past President of the Society for Judgment and Decision Making, a Guggenheim Fellow, and an elected member of the American Academy of Arts and Sciences. Shafir served as a member of President Barack Obama’s Advisory Council on Financial Capability, and as Vice-Chair of the World Economic Forum’s Global Agenda Council on Behavior. He was named one of Foreign Policy Magazine’s 100 Leading Global Thinkers in 2013. He edited “The Behavioral Foundations of Public Policy,” and co-authored, “Scarcity: Why Having Too Little Means So Much.” He received a BA from Brown University and a PhD from MIT.
SPEAKERS IN SESSION 2: Addressing AMR in a social, economic and political context - Approaches in research and action
Professor Koen Peeters Grietens heads the Socio-Ecological Health Research Unit at the Institute of Tropical Medicine in Antwerp and is a senior lecturer at Nagasaki University. He holds a PhD in Social and Cultural Anthropology and has conducted extensive research on sociocultural factors related to infectious disease transmission dynamics, community perceptions on health and illness, and their impact on the effectiveness of disease prevention, control and elimination strategies. His professional experience is characterized by high international mobility and extensive field research in low-income countries in West Africa, Latin America and South-East Asia.
Dr Franck Cesar Berthe speaker bio will be available soon.
Lena Hallengren is a Swedish politician of the Social Democratic Party who has been serving as Minister for Health and Social Affairs since 21 January 2019. Lena Hallengren has been a member of the Riksdag since the 2006 elections. In that capacity, she served as member of the Member of the Committee on Environment and Agriculture (2006-2009) and later chaired the Committee on Transport and Communications (2009-2010) and the Committee on Education (2014–2018).
Since 2020, Hallengren has also been a member of the Global Leaders Group on Antimicrobial Resistance, co-chaired by Sheikh Hasina and Mia Mottley.
SPEAKERS IN SESSION 3: The role of vaccines in drug resistance - adressing myths, misconceptions and opportunities for behaviour change
Dr Julie Leask is professor in the Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney and visiting professorial fellow at the National Centre for Immunisation Research and Surveillance. Her research focuses on behavioural science in public health, specifically vaccination uptake, programs and policy with 152 publications in the field.
She has a range of advisory roles with WHO: as chair of the working group on Measuring Behavioural and Social Drivers of Vaccination; member of the Immunization and Vaccines related Implementation Research advisory committee; the South East Asia Regional Immunization Technical Advisory Group; and previously, the Tailoring Immunization Programme Advisory Group of Experts for the WHO European Office. She is member of the Expert Advisory Group for Australia’s Regional (COVID-19) Vaccine Access and Health Security Initiative. She was winner of the Australian Financial Review 100 Women of Influence in 2019.
Dr Michael Dione is a veterinary epidemiologist at the International Livestock Research Institute (ILRI) based in Dakar, Senegal. Dione has strong experience in livestock health systems in East and West Africa. His research interest involves assessing animal health constraints by combining both field epidemiology and biological sampling; as well as developing and testing interventions that aim at preventing and controlling animal diseases including AMR in livestock. Dione also carries out research on the delivery of animal health inputs such as drugs and vaccines. He gives a specific focus on how to improve adoption of biosecurity measures and vaccines by smallholder livestock farmers.
SPEAKERS IN SESSION 4: Communicating the complexity of AMR
Sian Williams is Policy & Advocacy Adviser for Wellcome Trust’s Drug Resistant Infections Priority Programme. Her main interest lies in translating science for evidence-based policy, leading work focused on environmental dimensions of AMR and behaviour change for antimicrobial stewardship. Sian studied Natural Sciences at the University of Cambridge and holds a Masters in Science Communication from Imperial College London. Prior to joining Wellcome, Sian worked for the UK Government’s Global Food Security programme.
Dr Hathairat Kosiyaporn obtained her degree of doctor of medicine, at Ramathibodi Hospital, Mahidol University in 2013 and earned a master degree in health policy at the University of Edinburgh, Scotland in 2020. She was an internship at hospitals in Nan province for four years then she applied in Health Policy and System Research Fellowship programme at International Health Policy Program, Ministry of Public Health since 2017. She is interested in health system, health policy, behavioural science. She conducted project ‘Health system’s factors affecting health literacy in migrant health workers and migrant health volunteers: a case study of Samut Sakhon and Ranong, Thailand’ and ‘Strengthening the monitoring system of knowledge and awareness of antimicrobial use and antimicrobial resistance in Thai population’ during her fellowship programme.
Professor Sue Walker is the Director of Collections and Archives in Typography of the Design Star Doctoral Training Centre in Reading. She was Head of the Department of Typography from 1997 to 2007 and Head of the School of Arts and Communication Design from 2004 to 2007. From 2007 to 2011 she served as Dean of the Faculty of Arts and Humanities.
Professor Walker's research interests include analysis and description of graphic language, in particular the relationship between prescription and practice in everyday documents, typographic design for children and information design in public service.
SPEAKERS IN SESSION 5: The road ahead
Cass R. Sunstein is currently the Robert Walmsley University Professor at Harvard. He is also since 2021 a Senior Counselor at the Department of Homeland Security in Washington DC. He is the founder and director of the Program on Behavioral Economics and Public Policy at Harvard Law School. In 2018, he received the Holberg Prize from the government of Norway, sometimes described as the equivalent of the Nobel Prize for law and the humanities. In 2020, the World Health Organization appointed him as Chair of its technical advisory group on Behavioural Insights and Sciences for Health. From 2009 to 2012, he was Administrator of the White House Office of Information and Regulatory Affairs, and after that, he served on the President's Review Board on Intelligence and Communications Technologies and on the Pentagon's Defense Innovation Board. Mr. Sunstein has testified before congressional committees on many subjects, and he has advised officials at the United Nations, the European Commission, the World Bank, and many nations on issues of law and public policy. He serves as an adviser to the Behavioural Insights Team in the United Kingdom.
Mr. Sunstein is author of hundreds of articles and dozens of books, including Nudge: Improving Decisions about Health, Wealth, and Happiness (with Richard H. Thaler, 2008), Simpler: The Future of Government (2013), The Ethics of Influence (2015), #Republic (2017), Impeachment: A Citizen's Guide (2017), The Cost-Benefit Revolution (2018), On Freedom (2019), Conformity (2019), How Change Happens (2019), and Too Much Information (2020). He is now working on a variety of projects involving the regulatory state, "sludge" (defined to include paperwork and similar burdens), fake news, and freedom of speech.
Dr Stefan Swartling Peterson is Professor of Global Health at Uppsala University, and Karolinska Institutet, both in Sweden, and Makerere University in Uganda. Between 2016 and 2020 Dr Swartling Peterson was Associate Director, Programme Division, and Chief of Health at UNICEF.
As a health systems researcher and medical doctor, Dr Peterson did extensive field work in Tanzania and Uganda, and worked with different ministries of health, and organizations such as the World Health Organization (WHO). He implemented projects supported by Swedish International Development Cooperation Agency (SIDA), the Gates Foundation, and the European Union. He was a co-founder of Médecins Sans Frontières Sweden and the CCM Task Force Operations Research Group.
Dr Peterson is a medical doctor with degrees in Medicine, Public Health and a PHD in International Paediatrics.
Professor Hanan H. Balkhy is the first appointed Assistant Director-General for the Antimicrobial Resistance Division (AMR) at the World Health Organization (WHO), which is a flagship program and has the mandate to lead the human health response to the emergence of antimicrobial resistance along with the relevant stakeholders. Dr Balkhy is a Professor of Pediatric Infection Diseases with over two decades of experience in the field of infectious diseases and Infection Prevention and Control (IPC), a clinician and a researcher with over 150 publications. Prior to her appointment she was the Executive Director, Infection Prevention and Control, at the Ministry of National Guard (MNG) and the Director of the Gulf Cooperation Council Centre for Infection Control. She led the WHO Collaborating Centre for IPC and AMR in Saudi Arabia between 2009-2019. Dr Balkhy is also the first appointed chair for the Infectious Disease Research Unit at King Abdullah International Medical Research Center at King Saud bin Abdulaziz University for Health Sciences in Riyadh, Saudi Arabia. She was the Editor-in-Chief of the Journal of Infection and Public Health from 2009-2019.
Dr Balkhy is a graduate of King Abdulaziz University in Jeddah, Saudi Arabia. She completed her pediatric residency at Massachusetts General Hospital in Boston, USA. Dr Balkhy has served as an expert on many WHO committees including: the Review Committee on the Role of the International Health Regulations (2005) in the Ebola Outbreak and Response, the Advisory Group on Integrated Surveillance and Antimicrobial Resistance (AGISAR), the Strategic and Technical Advisory Group on Antimicrobial Resistance (STAG-AMR), and the International Health Regulations Review Committee (IHR-RC).